The neurochemistry of human aggression

Advances in Genetics

Volumn 75, Issue , 2011, Pages 151-169

  Yanowitch, Rachel ^a   Coccaro, Emil F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aggression; Dopamine; Norepinephrine; Serotonin

Indexed keywords

EID: 81055149910     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380858-5.00005-8     Document Type: Chapter

References (130)

1. Alia-Klein N., Goldstein R.Z., Kriplani A., Logan J., Tomasi D., Williams B., Telang F., Shumay E., Biegon A., Craig I.W., Henn F., Wang G.J., Volkow N.D., Fowler J.S. Brain monoamine oxidase. A activity predicts trait aggression. J. Neurosci. 2008, 28(19):5099-5104.
2. Arias-Carrión O., Pöppel E. Dopamine, learning and reward-seeking behavior. Act. Neurobiol. Exp. 2007, 67(4):481-488.
3. Asberg M., Traksman L., Thoren P. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor. Arch. Gen. Psychiatry 1976, 33:1193-1197.
4. Berman M., Taylor S., Marged B. Morphine and human aggression. Addict. Behav. 1993, 18:263-268.
5. Birmaher B., Stanley M., Greenhill L., Twomey J., Gavrilescu A., Rabinovich H. Platelet imipramine binding in children and adolescents with impulsive behavior. J. Am. Acad. Child Adolesc. Psychiatry 1990, 29:914-918.
6. Browman K.E., Curzon P., Pan J.B., Molesky A.L., Komater V.A., Decker M.W., Brioni J.D., Moreland R.B., et al. A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats. Pharmacol. Biochem. Behav. 2005, 82(1):148-155.
7. Brown A.S., Gershon S. Dopamine and depression. J. Neural Transm. Gen. Sect. 1993, 91(2-3):75-109. Review.
8. Brown G.L., Goodwin F.K., Ballenger J.C., Goyer P.F., Major L.F. Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979, 1:131-139.
9. Brown G.L., Ebert M.H., Goyer P.F., et al. Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. Am. J. Psychiatry 1982, 139:741-746.
10. Castellanos F.X., Elia J., Kreusi M.J.P., Gulotta C.S., Mefford I.N., Potter W.Z., Ritchie G.F., Rapoport J.L. Cerebrospinal fluid monoamine metabolites in boys with attention deficit hyperactivity disorder. Psychiatry Res. 1994, 52:305-316.
11. Cervantes M.C., Delville Y. Serotonin 5-HT1A and 5-HT3 receptors in an impulsive-aggressive phenotype. Behav. Neurosci. 2009, 123(3):589-598.
12. Cervantes M.C., Biggs E.A., Delville Y. Differential responses to serotonin receptor ligands in an impulsive-aggressive phenotype. Behav. Neurosci. 2010, 124(4):455-469.
13. Coccaro E.F. Central neurotransmitter function in human aggression and impulsivity. Neurobiology and Clinical Views on Aggression and Impulsivity 1998, 143-168. Chichester, Wiley, UK. M. Maes, E.F. Coccaro (Eds.).
14. Coccaro E.F., Kavoussi R.J. The neuropsychopharmacologic challenge in biological psychiatry. Clin. Chem. 1994, 40:319-327.
15. Coccaro E.F., Kavoussi R.J. GH response to intravenous clonidine challenge: Absence of relationship with behavioral irritability, aggression, or impulsivity in human subjects. Psychiatry Res. 2010, 178:443-445.
16. Coccaro E.F., Lee R. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: Reciprocal relationships with impulsive aggression in human subjects. J. Neural Transm. 2010, 117(2):241-248.
17. Coccaro E.F., Siever L.J. Pathophysiology and treatment of aggression. Psychopharmacology: The Fifth Generation of Progress 2002, 1709-1723. Lippincott Williams & Wilkins, Philadelphia. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
18. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Mohs R.C., Davis K.L. Serotonergic studies in affective and personality disorder: Correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry 1989, 46:587-599.
19. Coccaro E.F., Lawrence T., Trestman R., Gabriel S., Klar H.M., Siever L.J. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers. Psychiatry Res. 1991, 39(2):129-139.
20. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., Csernansky J.G. Impulsive aggression in personality disorder: Correlates with 3-H-Paroxetine binding in the platelet. Arch. Gen. Psychiatry 1996, 53:531-536.
21. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R.L. Central serotonin activity and aggression: Inverse relationship with prolactin response to d-fenfluramine, but Not CSF 5-HIAA concentration, in human subjects. Am. J. Psychiatry 1997, 154:1430-1435.
22. Coccaro E.F., Kavoussi R.J., Hauger R.L. Serotonin function and antiaggressive responses to fluoxetine: A pilot study. Biol. Psychiatry 1997, 42:546-552.
23. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R.L. Central serotonin and aggression: Inverse relationship with prolactin response to d-fenfluramine, but not with CSF 5-HIAA concentration in human subjects. Am. J. Psychiatry 1997, 154:1430-1435.
24. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Psychopharmacology 1998, 138:9-15.
25. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., Ferris C.F. Cerebrospinal fluid vasopressin: Correlates with aggression and serotonin function in personality disordered subjects. Arch. Gen. Psychiatry 1998, 55:708-714.
26. Coccaro E.F., Lee R., McCloskey M. Norepinephrine function in personality disorder: Plasma free MHPG correlates inversely with life history of aggression. CNS Spectr. 2003, 8:731-736.
27. Coccaro E.F., Lee R., Kavoussi R.J. Aggression, Suicidality, and Intermittent Explosive Disorder: Serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology 2010, 35:435-444.
28. Coccaro E.F., Lee R., Kavoussi R.J. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J. Psychiatr. Res. 2010, 44(3):137-142.
29. Coid J., Allolio B., Rees L.H. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983, 2:545-546.
30. Couppis M.H., Kennedy C.H. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology (Berl.) 2008, 197(3):449-456.
31. Curzon G. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding. Adv. Exp. Med. Biol. 1991, 294:377-388.
32. Daw N.D., Kakade S., Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002, 15:603-616.
33. de Almeida R.M., Ferrari P.F., Parmigiani S., Miczek K.A. Escalated aggressive behavior: Dopamine, serotonin and GABA. Eur. J. Pharmacol. 2005, 526:51-64.
34. De Simoni M.G., Dal Toso G., Fodritto F., Sokola A., Algeri S. Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences. Brain Res. 1987, 411:81-88.
35. Denenberg V.H., Kim D.S., Palmiter R.D. The role of dopamine in learning, memory, and performance of a water escape task. Behav. Brain Res. 2004, 148(1-2):73-78.
36. Devos D., Labyt E., Derambure P., Bourriez J.L., Cassim F., Guieu J.D., Destée A., Defebvre L. Effect of l-dopa on the pattern of movement-related (de)synchronisation in advanced Parkinson's disease. Neurophysiol. Clin. 2003, 33(5):203-212.
37. Diehl D.J., Gershon S. The role of dopamine in mood disorders. Compr. Psychiatry 1992, 33(2):115-120. Review.
38. Dourish C.T. Multiple serotonin receptors: Opportunities for new treatments for obesity?. Obes. Res. 1995, 3(Suppl. 4):449S-462S.
39. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.C., Grosmark A., Sotnikova T.D., Gainetdinov R.R., Caron M.G., Nicolelis M.A. Dopaminergic control of sleep-wake states. J. Neurosci. 2006, 26(41):10577-10589.
40. Engelborghs S., Vloeberghs E., Le Bastard N., Van Buggenhout M., Mariën P., Somers N., Nagels G., Pickut B.A., De Deyn P.P. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem. Int. 2008, 52(6):1052-1060.
41. Enna S.J., McCarson K.E. The role of GABA in the mediation and perception of pain. Adv. Pharmacol. 2006, 54:1-27. Review.
42. Ferris C.F., Stolberg T., Delville Y. Serotonin regulation of aggressive behavior in male golden hamsters Mesocricetus auratus. Behav. Neurosci. 1999, 113:804-815.
43. Gardner D.L., Lucas P.B., Cowdry R.W. CSF metabolites in borderline personality disorder compared with normal controls. Biol. Psychiatry 1990, 28:247-254.
44. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
45. Gershon M.D. Review article: Serotonin receptors and transporters-Roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 2004, 20(Suppl. 7):3-14.
46. Grigorenko E.L., De Young C.G., Eastman M., Getchell M., Haeffel G.J., Klinteberg B., Koposov R.A., Oreland L., Pakstis A.J., Ponomarev O.A., Ruchkin V.V., Singh J.P., Yrigollen C.M. Aggressive behavior, related conduct problems, and variation in genes affecting dopamine turnover. Aggress. Behav. 2010, 36(3):158-176.
47. Heijtz R.D., Kolb B., Forssberg H. Motor inhibitory role of dopamine D1 receptors: Implications for ADHD. Physiol. Behav. 2007, 92(1-2):155-160.
48. Heneka M.T., Nadrigny F., Regen T., Martinez-Hernandez A., Dumitrescu-Ozimek L., Terwel D., Jardanhazi-Kurutz D., Walter J., Kirchhoff F., Hanisch U.K., Kummer M.P. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. USA 2010, 17:6058-6063.
49. Hernandez L., Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 1988, 42:1705-1712.
50. Hull E.M., Eaton R.C., Moses J., Lorrain D. Copulation increases dopamine activity in the medial preoptic area of male rats. Life Sci. 1993, 52:935-940.
51. Joppa M.A., Rowe R.K., Meisel R.L. Effects of serotonin 1A or 1B receptor agonists on social aggression in male and female Syrian hamsters. Pharmacol. Biochem. Behav. 1996, 58:349-353.
52. Joyce P.R., McHugh P.C., McKenzie J.M., Sullivan P.F., Mulder R.T., Luty S.E., Carter J.D., Frampton C.M., Robert Cloninger C., Miller A.M., Kennedy M.A. A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychol. Med. 2006, 36(6):807-813.
53. Kantrowitz J., Citrome L., Javitt D. GABA(B) receptors, schizophrenia and sleep dysfunction: A review of the relationship and its potential clinical and therapeutic implications. CNS Drugs 2009, 23(8):681-691.
54. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 1996, 153:436-476.
55. Kruesi M.J.P., Rapoport J.L., Hamberger S., Hibbs E., Potter W.Z., Lenane M., Brown G.L. Cerebrospinal fluid metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiatry 1990, 47:419-462.
56. Kumar K.K., Tung S., Iqbal J. Bone loss in anorexia nervosa: Leptin, serotonin, and the sympathetic nervous system. Ann. N. Y. Acad. Sci. 2010, 1211:51-65.
57. Kunisato Y., Okamoto Y., Okada G., Aoyama S., Demoto Y., Munakata A., Nomura M., Onoda K., Yamawaki S. Modulation of default-mode network activity by acute tryptophan depletion is associated with mood change: A resting state functional magnetic resonance imaging study. Neurosci. Res. 2010, 69:129-134.
58. Lam D.D., Garfield A.S., Marston O.J., Shaw J., Heisler L.K. Brain serotonin system in the coordination of food intake and body weight. Pharmacol. Biochem. Behav. 2010, 97(1):84-91.
59. Lee R., Petty F., Coccaro E.F. Cerebrospinal fluid GABA concentration: Relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J. Psychiatric. Res. 2008, 43:353-359.
60. Lee R., Ferris C., Van de Kar L.D., Coccaro E.F. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinology 2009, 34:1567-1573.
61. Lee R., Chong B., Coccaro E.F. Growth hormone responses to GABA-B receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects. Psychopharmacology (Berl) 2011, 215(1):41-48.
62. Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J. Neurochem. 1993, 60:2319-2322.
63. Lidberg L., Tuck J.R., Asberg M., Scalia-Tomba G.P., Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psych. Scand. 1985, 71:230-236.
64. Lima M.M., Andersen M.L., Reksidler A.B., Silva A., Zager A., Zanata S.M., Vital M.A., Tufik S. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav. Brain Res. 2008, 188(2):406-411.
65. Limson R., Goldman D., Roy A., Lamparski D., Ravitz B., Adinoff B., Linnoila M. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch. Gen. Psychiatry 1991, 48:437-441.
66. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxylndolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983, 33:2609-2614.
67. Meyer J.H., Wilson A.A., Rusjan P., Clark M., Houle S., Woodside S., Arrowood J., Martin K., Colleton M. Serotonin2A receptor-binding potential in people with aggressive and violent behaviour. J. Psychiatry Neurosci. 2008, 33(6):499-508.
68. Miczek K.A., Faccidomo S., de Almeida R.M.M., Bannai M., Fish E.W., DeBold J.F. Escalated aggressive behavior: New pharmacotherapeutic approaches and opportunities. Ann. N. Y. Acad. Sci. 2004, 1036:336-355.
69. Moller S.E., Mortensen E.L., Breum L., Alling C., Larsen O.G., Boge-Rasmussen T., Jensen C., Bennicke K. Aggression and personality: Association with amino acids and monoamine metabolites. Psychol. Med. 1996, 26:323-331.
70. Monti J.M. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep Med. Rev. 2010, 14(5):319-327.
71. Monti J.M., Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog. Brain Res. 2008, 172:625-646.
72. Monti J.M., Monti D. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep. Life Sci. 2000, 66(21):1999-2012.
73. Munafò M.R., Yalcin B., Willis-Owen S.A., Flint J. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: Meta-analysis and new data. Biol. Psychiatry 2008, 63(2):197-206.
74. Naheed M., Green B. Focus on clozapine. Curr. Med. Res. Opin. 2001, 17(3):223-229.
75. Nemoda Z., Lyons-Ruth K., Szekely A., Bertha E., Faludi G., Sasvari-Szekely M. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behav. Brain Funct. 2010, 6:4.
76. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Reynolds D., Mitropoulou V., Sprung L., Shaw R.B., Koenigsberg H., Platholi J., Silverman J., Siever L.J. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch. Gen. Psychiatry 2002, 59(7):621-629.
77. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 2002, 67(1):53-83. Review.
78. Oak J.N., Oldenhof J., Van Tol H.H. The dopamine D(4) receptor: One decade of research. Eur. J. Pharmacol. 2000, 405(1-3):303-327. Review.
79. Olivier B., Mos J., van Oorschot R., Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 1995, 28:80-90.
80. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor-binding potential measured by PET using [C-11]WAY-100635. Brain Res. 2002, 954:173-182.
81. Peddeer J. Psychoanalytic views of aggression: Some theoretical problems. Br. J. Med. Psychol. 1992, 65:95-106.
82. Pettit H.O., Justice J.B. Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 1991, 539:94-102.
83. Pfaus J.G., Damsma G., Nomikos G.G., Wenkstern D.G., Blaha C.D., Phillips A.G., Fibiger H.C. Sexual behavior enhances central dopamine transmission in the male rat. Brain Res. 1990, 530:345-348.
84. Pihl R.-O., Young S., Harden P., Plotnick S., Chamberlain B., Ervin F.R. Acute effect of altered tryptophan levels and alcohol on aggression in normal human males. Psychopharmacology 1995, 119:353-360.
85. Popova N.K. From gene to aggressive behavior: The role of brain serotonin. Neurosci. Behav. Physiol. 2008, 38(5):471-475.
86. Popova N.K., Naumenko V.S., Plyusnina I.Z., Kulikov A.V. Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. J. Neurosci. Res. 2005, 80:286-292.
87. Popova N.K., Naumenko V.S., Plyusnina I.Z. Involvement of brain serotonin 5-HT1A receptors in genetic predisposition to aggressive behavior. Neurosci. Behav. Physiol. 2007, 37:631-635.
88. Prochazka H., Agren H. Self-rated aggression and cerebral monoaminergic turnover. Sex differences in patients with persistent depressive disorder. Eur. Arch Psychiatry Clin. Neurosci. 2003, 253(4):185-192.
89. Pucilowski O., Valzelli L. Evidence of norepinephrine-mediated suppression of para-chlorophenylalanine-induced muricidal behavior. Pharmacol. Res. Commun. 1985, 17:983-989.
90. Pucilowski O., Kozak W., Valzelli L. Effect of 6-OHDA injected into the locus coeruleus on apomorphine-induced aggression. Pharmacol. Biochem. Behav. 1986, 24:773-775.
91. Pucilowski O., Trzaskowska E., Kostowski W., Valzelli L. Norepinephrine-mediated suppression of apomorphine-induced aggression and locomotor activity in the rat amygdala. Pharmacol. Biochem. Behav. 1987, 26(2):217-222.
92. Ranaldi R., Pocock D., Zereik R., Wise R.A. Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous d-amphetamine self-administration. J. Neurosci. 1999, 19:4102-4109.
93. Ricci L.A., Rasakham K., Grimes J.M., Melloni R.H. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol. Biochem. Behav. 2006, 85:1-11.
94. Ricci L.A., Schwartzer J.J., Melloni R.H. Alterations in the anterior hypothalamic dopamine system in aggressive adolescent AAS-treated hamsters. Horm. Behav. 2009, 55:348-355.
95. Rosell D.R., Thompson J.L., Slifstein M., Xu X., Frankle W.G., New A.S., Goodman M., Weinstein S.R., Laruelle M., Abi-Dargham A., Siever L.J. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol. Psychiatry 2010, 67(12):1154-1162.
96. Ruhé H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Mol. Psychiatry 2007, 12(4):331-359.
97. Sandman C.A., Barron J.L., Colman H. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. Am. J. Ment. Retard. 1990, 95:93-102.
98. Sandman C.A., Hedrick W., Taylor D.V., Marion S.D., Touchette P., Barron J.L., Martinezzi V., Steinberg R.M., Crinella F.M. Long-term effects of naltrexone on self-injurious behavior. Am. J. Ment. Retard. 2000, 105:103-117.
99. Santana N., Mengod G., Artigas F. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 2009, 19:849-860.
100. Sawynok J. GABAergic mechanisms in antinociception. Prog. Neuropsychopharmacol. Biol. Psychiatry 1984, 8(4-6):581-586.
101. Schwartzer J.J., Melloni R.H. Dopamine activity in the lateral anterior hypothalamus modulates AAS-induced aggression through D2 but not D5 receptors. Behav. Neurosci. 2010, 124(5):645-655.
102. Schwartzer J.J., Melloni R.H. Anterior hypothalamic dopamine D2 receptors modulate adolescent anabolic/androgenic steroid-induced offensive aggression in the Syrian hamster. Behav. Pharmacol. 2010, 21(4):314-322.
103. Schwartzer J.J., Ricci L.A., Melloni R.H. Interactions between the dopaminergic and GABAergic neural systems in the lateral anterior hypothalamus of aggressive AAS-treated hamsters. Behav. Brain Res. 2009, 203(1):15-22.
104. Seo D., Patrick C.J., Kennealy P.J. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav. 2008, 13(5):383-395.
105. Sheard M., Manini J., Bridges C., Wapner A. The effect of lithium on impulsive aggressive behavior in man. Am. J. Psychiatry 1976, 133:1409-1413.
106. Siever L.J. Neurobiology of aggression and violence. Am. J. Psychiatry 2008, 165(4):429-442.
107. Siever L.J., Davis K.L. A psychobiological perspective on the personality disorders. Am. J. Psychiatry 1991, 148(12):1647-1658. Review.
108. Siever L.J., Buchsbaum M.S., New A.S., Spiegel-Cohen J., Wei C.T., Hazlett E., Sevin E., Nunn M., Mitropoulou V. D1-Fenfluramine response in impulsive personality disorder assessed with 18F-deoxyglucose positron emission tomography. Neuropsychopharmacology 1999, 20:413-423.
109. Snodgrass S.R. GABA and epilepsy: Their complex relationship and the evolution of our understanding. J. Child Neurol. 1992, 7(1):77-86. Review.
110. Sofuoglu M., Sewell R.A. Norepinephrine and stimulant addiction. Addict. Biol. 2009, 14(2):119-129. Review.
111. Soloff P.H., Price J.C., Mason N.S., Becker C., Meltzer C.C. Gender, personality, and serotonin-2A receptor-binding in healthy subjects. Psychiatry Res. 2010, 181(1):77-84.
112. Spiga R., Cherek D.R., Roache J.D., Cowan K.A. The effects of codeine on human aggressive responding. Int. Clin. Psychopharmacol. 1990, 5:195-204.
113. Spivak B., Roitman S., Vered Y., Mester R., Graff E., Talmon Y., Guy N., Gonen N., Weizman A. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin. Neuropharmacol. 1998, 21(4):245-250.
114. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1:214-216.
115. Stanley M.S., Viggilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982, 216:1337-1339.
116. Tadić A., Victor A., Başkaya O., von Cube R., Hoch J., Kouti I., Anicker N.J., Höppner W., Lieb K., Dahmen N. Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder. Am. J. Med. Genet. B. 2009, 150:487-495.
117. Takahashi A., Shimamoto A., Boyson C.O., DeBold J.F., Miczek K.A. GABA(B) receptor modulation of serotonin neurons in the dorsal raphé nucleus and escalation of aggression in mice. J. Neurosci. 2010, 30(35):11771-11780.
118. Takahashi A., Quadros I.M., de Almeida R.M., Miczek K.A. Brain serotonin receptors and transporters: Initiation vs. termination of escalated aggression. Psychopharmacology (Berl.) 2011, 213(2-3):183-212.
119. Tanaka M., Yoshida M., Emoto H., Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: Basic studies. Eur. J. Pharmacol. 2000, 405(1-3):397-406. Review.
120. Thoa N.B., Eichelman B., Richardson J.S., Jacobowitz D. 6-Hydroxydopa depletion of brain norepinephrine and the function of aggressive behavior. Science 1972, 178(56):75-77.
121. Treiman D.M. GABA ergic mechanisms in epilepsy. Epilepsia 2001, 42(Suppl. 3):8-12. Review.
122. Van Erp A.M.M., Miczek K.A. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J. Neurosci. 2000, 20(24):9320-9325.
123. Wassef A.A., Dott S.G., Harris A., Brown A., O'Boyle M., Meyer W.J., Rose R.M. Critical review of GABA-ergic drugs in the treatment of schizophrenia. J. Clin. Psychopharmacol. 1999, 19(3):222-232. Review.
124. Weiss F., Paulus M., Lorang M.T., Koob G.F. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: Effects of acute and repeated administration. J. Neurosci. 1992, 12:4372-4380.
125. Welch J.T., Lim D.S. The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. Bioorg. Med. Chem. 2007, 15(21):6659-6666.
126. White S.M., Kucharik R.F., Moyer J.A. Effects of serotonergic agents on isolation-induced aggression. Pharmacol. Biochem. Behav. 1991, 39:729-736.
127. Wise R.A. Dopamine, learning, and motivation. Nat. Rev. Neurosci. 2004, 5:483-495.
128. Witte A.V., Flöel A., Stein P., Savli M., Mien L.K., Wadsak W., Spindelegger C., Moser U., Fink M., Hahn A., Mitterhauser M., Kletter K., Kasper S., Lanzenberger R. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum. Brain Mapp. 2009, 30(8):2558-2570. Erratum in: Hum. Brain Mapp. 2010 Feb; 31(2): 339.
129. Wong P.T., Feng H., Teo W.L. Interaction of the dopaminergic and serotonergic systems in the rat striatum: Effects of selective antagonists and uptake inhibitors. Neurosci. Res. 1995, 23:115-119.
130. Xu L., Yu B.P., Chen J.G., Luo H.S. Mechanisms mediating serotonin-induced contraction of colonic myocytes. Clin. Exp. Pharmacol. Physiol. 2007, 34(1-2):120-128.